Magee MS - Search Results

1

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.

Magee MS, Kraft CL, Abraham TS, Baybutt TR, Marszalowicz GP, Li P, Waldman SA, Snook AE. Magee MS, et al. Oncoimmunology. 2016 Sep 2;5(10):e1227897. doi: 10.1080/2162402X.2016.1227897. eCollection 2016. Oncoimmunology. 2016. PMID: 27853651 Free PMC article.

2

Colorectal cancer immunotherapy.

Xiang B, Snook AE, Magee MS, Waldman SA. Xiang B, et al. Among authors: magee ms. Discov Med. 2013 May;15(84):301-8. Discov Med. 2013. PMID: 23725603 Free PMC article. Review.

3

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.

Marszalowicz GP, Snook AE, Magee MS, Merlino D, Berman-Booty LD, Waldman SA. Marszalowicz GP, et al. Among authors: magee ms. Oncotarget. 2014 Oct 15;5(19):9460-71. doi: 10.18632/oncotarget.2455. Oncotarget. 2014. PMID: 25294806 Free PMC article.

4

Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.

Magee MS, Snook AE. Magee MS, et al. Discov Med. 2014 Nov;18(100):265-71. Discov Med. 2014. PMID: 25425467 Free article. Review.

5

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.

Magee MS, Abraham TS, Baybutt TR, Flickinger JC Jr, Ridge NA, Marszalowicz GP, Prajapati P, Hersperger AR, Waldman SA, Snook AE. Magee MS, et al. Cancer Immunol Res. 2018 May;6(5):509-516. doi: 10.1158/2326-6066.CIR-16-0362. Epub 2018 Apr 3. Cancer Immunol Res. 2018. PMID: 29615399 Free PMC article.

6

GUCY2C-targeted cancer immunotherapy: past, present and future.

Snook AE, Magee MS, Waldman SA. Snook AE, et al. Among authors: magee ms. Immunol Res. 2011 Dec;51(2-3):161-9. doi: 10.1007/s12026-011-8253-7. Immunol Res. 2011. PMID: 22038530 Free PMC article. Review.

7

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.

Valentino MA, Lin JE, Snook AE, Li P, Kim GW, Marszalowicz G, Magee MS, Hyslop T, Schulz S, Waldman SA. Valentino MA, et al. Among authors: magee ms. J Clin Invest. 2011 Sep;121(9):3578-88. doi: 10.1172/JCI57925. Epub 2011 Aug 25. J Clin Invest. 2011. PMID: 21865642 Free PMC article.

8

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.

Snook AE, Magee MS, Marszalowicz GP, Schulz S, Waldman SA. Snook AE, et al. Among authors: magee ms. Cancer Immunol Immunother. 2012 May;61(5):713-23. doi: 10.1007/s00262-011-1133-0. Epub 2011 Nov 6. Cancer Immunol Immunother. 2012. PMID: 22057677 Free PMC article.

9

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

Magee MS, Snook AE, Marszalowicz GP, Waldman SA. Magee MS, et al. Biomark Med. 2013 Feb;7(1):23-35. doi: 10.2217/bmm.12.110. Biomark Med. 2013. PMID: 23387482 Free PMC article. Review.

10

Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.

Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE. Witek M, et al. Among authors: magee ms. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1188-95. doi: 10.1016/j.ijrobp.2013.12.043. Int J Radiat Oncol Biol Phys. 2014. PMID: 24661671 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page